|
Tags: mobile edit mobile web edit |
| Line 1: |
Line 1: |
| {{Navbox
| | '''List of antiarrhythmic agents:''' |
| | name = Antiarrhythmic agents
| |
| | title = [[Antiarrhythmic agent]]s ([[ATC code C01#C01B|C01B]])
| |
| | state = {{{state|autocollapse}}}
| |
| |listclass = hlist
| |
|
| |
|
| |group1 = [[Channel blocker]]s
| | * [[Amiodarone]] |
| |list1 = {{Navbox|subgroup
| |
| | |
| | group1 = [[Antiarrhythmic agent#Class I agents|class I]]<BR>([[sodium channel blocker|Na<sup>+</sup> channel blockers]])
| |
| | list1 = {{Navbox|subgroup
| |
| | |
| | group1 = class Ia ([[Cardiac action potential#Phase 0|Phase 0]]→ and [[Cardiac action potential#Phase 3|Phase 3]]→)
| |
| | list1 =
| |
| * [[Ajmaline]] | |
| * [[Disopyramide]] | | * [[Disopyramide]] |
| * [[Dihydroquinidine|Hydroquinidine]]
| |
| * [[Lorajmine]]
| |
| * [[Prajmaline]]
| |
| * [[Procainamide]]<sup>#</sup>
| |
| * [[Quinidine]]<sup>#</sup>
| |
| * [[Sparteine]]
| |
|
| |
| | group2 = class Ib ([[Cardiac action potential#Phase 3|Phase 3]]←)
| |
| | list2 =
| |
| * ''[[Intravenous therapy|IV]]''
| |
| ** [[Lidocaine]]<sup>#</sup>
| |
| * ''[[enteral]]''
| |
| ** [[Aprindine]]
| |
| ** [[Mexiletine]]
| |
| ** [[Tocainide]]
| |
|
| |
| | group3 = class Ic ([[Cardiac action potential#Phase 0|Phase 0]]→)
| |
| | list3 =
| |
| * [[Encainide]]<sup>‡</sup>
| |
| * [[Ethacizine]]
| |
| * [[Flecainide]]
| |
| * [[Indecainide]]<sup>‡</sup>
| |
| * [[Lorcainide]]
| |
| * [[Moracizine]]<sup>‡</sup>
| |
| * [[Propafenone]]
| |
|
| |
| }}
| |
|
| |
| | group3 = [[Antiarrhythmic agent#Class III agents|class III]]<BR>([[Cardiac action potential#Phase 3|Phase 3]]→, [[potassium channel blocker|K<sup>+</sup> channel blockers]])
| |
| | list3 =
| |
| * [[Amiodarone]]
| |
| * [[Bretylium]]
| |
| * [[Bunaftine]]
| |
| * [[Celivarone]]<sup>†</sup>
| |
| * [[Dofetilide]] | | * [[Dofetilide]] |
| * [[Dronedarone]] | | * [[Dronedarone]] |
| * [[E-4031]]<sup>†</sup> | | * [[Flecainide]] |
| * [[Ibutilide]] | | * [[Ivabradine]] |
| * [[Nifekalant]] | | * [[Mexiletine]] |
| * [[Sotalol]] | | * [[Procainamide]] |
| * [[Tedisamil]] | | * [[Propafenone]] |
| * [[Vernakalant]]
| |
| | |
| | group4 = [[Antiarrhythmic agent#Class IV agents|class IV]]<br/>([[Cardiac action potential#Phase 4|Phase 4]]→, [[calcium channel blocker|Ca<sup>2+</sup> channel blockers]])
| |
| | list4 =
| |
| * [[Diltiazem]]
| |
| * [[Verapamil]]<sup>#</sup>
| |
| | |
| }}
| |
| | |
| |group2 = [[Receptor (biochemistry)|Receptor]] [[agonist]]s<BR>and [[Receptor antagonist|antagonist]]s
| |
| |list2 = {{Navbox|subgroup
| |
| | |
| | group2 = [[Antiarrhythmic agent#Class II agents|class II]]<br/>([[Cardiac action potential#Phase 4|Phase 4]]→, [[beta blocker|β blocker]]s)
| |
| | list2 =
| |
| * [[Nadolol]]
| |
| * [[Pindolol]]
| |
| * [[Propranolol]]
| |
| * ''cardioselective''
| |
| ** [[Acebutolol]]
| |
| ** [[Atenolol]]
| |
| ** [[Esmolol]]
| |
| ** [[Landiolol]]
| |
| ** [[Metoprolol]]
| |
| | |
| | group5 = [[adenosine A1 receptor|A<sub>1</sub> agonist]]
| |
| | list5 =
| |
| * [[Adenosine]]
| |
| * [[Benzodiazepine]]s
| |
| * [[Barbiturate]]s
| |
| | |
| | group6 = [[Muscarinic acetylcholine receptor M2|M<sub>2</sub>]]
| |
| | list6 =
| |
| * [[muscarinic antagonist]]: [[Atropine]]
| |
| * [[Disopyramide]]
| |
| * [[Quinidine]]<BR>[[muscarinic agonist]]: [[Digoxin]]
| |
| | |
| | group7 = [[Adrenergic receptor#.CE.B1 receptors|α receptors]]
| |
| | list7 =
| |
| * [[Amiodarone]]
| |
| * [[Bretylium]]
| |
| * [[Quinidine]] | | * [[Quinidine]] |
| * [[Verapamil]]
| | {{no-index-template}} |
| | |
| }}
| |
| | |
| | group8 = [[Ion transporter]]s
| |
| | list8 = {{Navbox|subgroup
| |
| | |
| | group1 = [[Na+/K+-ATPase|Na<sup>+</sup>/ K<sup>+</sup>-ATPase]]
| |
| | list1 =
| |
| * [[Digitoxin]]
| |
| * [[Digoxin]]
| |
| * [[Ouabain]]
| |
| | |
| }}
| |
| | |
| | group9 =
| |
| | list9 = {{PharmNavFootnote}}
| |
| | |
| }}<noinclude>
| |
| {{collapsible option}}
| |
| [[Category:Antiarrhythmic agents]]
| |
| [[Category:Drug templates by ATC]]
| |
| </noinclude>
| |
